This site contains forward-looking statements about our business, including the timing and results of our clinical trials, potential indications for our product candidates, development timelines and the future financial results. Biopharmaceutical development inherently involves significant risks and uncertainties, including the risks outlined under "Risk Factors" and elsewhere in our preliminary prospectus. Our actual results may differ materially from our expectations due to these risks and uncertainties, including our near term dependence on our lead product candidate, Linjeta™, and risks relating to regulatory approval, research and development, intellectual property protection and litigation, existing and future competition, industry environment, ability to raise sufficient capital and other matters. Biodel undertakes no duty or obligation to update any forward-looking statements contained in this site as a result of new information, future events or changes in Biodel´s expectations. Further information on the factors and risks that could affect Biodel´s business, financial condition, and results of operations are contained in Biodel´s public disclosure filings with the U.S. Securities and Exchange Commission, which are available at www.sec.gov.
Although we have attempted to provide accurate information on our website, we assume no responsibility for the accuracy of the information. In particular, we may not update our website on a daily or other regular basis. As such, the information and materials contained on our website may be out of date or include omissions or other errors. We may change the information provided on our website at any time without notice. All information provided on our website is provided "AS IS" without warranty of any kind. Biodel its affiliates and collaborators disclaim all warranties, express or implied, including those of merchantability and fitness for a particular purpose.